Market Place
Sourcing Support
AccurEdit Therapeutics` ART001 Obtains FDA Orphan Drug Designation
25 Mar 2025 //
PR NEWSWIRE
Accuredit Therapeutics and N1 Life Form JV Named `Napoltec`
13 Jan 2022 //
PRNEWSWIRE
Accuredit Therapeutics Appointed Dr. Fuxin Shi as Head of New Drug Discovery
29 Nov 2021 //
PRNEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.